INFLAMMATION Part 6: Chemical Mediators: CYTOKINES: Interleukins & Chemokines
16:25
YouTubeilovepathology
INFLAMMATION Part 6: Chemical Mediators: CYTOKINES: Interleukins & Chemokines
Click here to view Inflammation part 5: https://www.youtube.com/watch?v=Yp4O1WGEz9w&t=2s 5. Cytokines are low molecular weight regulatory proteins or glycoproteins Secreted by white blood cells and various other cells in the body in response to a number of stimuli. Mainly by activated lymphocytes, macrophages, and dendritic cells, but also ...
192.2K viewsJan 5, 2018
Related Products
Cytokine vs Interleukin
Interleukin Signaling Pathway
Interleukin Table
#Interleukin Functions
What is Interleukin 6?
What is Interleukin 6?
news-medical.netMar 19, 2015
Interferons
Interferons
YouTubeFeb 18, 2018
Top videos
Interleukins and its role in immune system | Interleukin function
14:52
Interleukins and its role in immune system | Interleukin function
YouTubeAnimated biology With arpan
27.2K viewsFeb 28, 2024
Immunology - Interleukin 6 (IL6) physiology and IL6 antagonist pharmacology Tocilizumab
6:31
Immunology - Interleukin 6 (IL6) physiology and IL6 antagonist pharmacology Tocilizumab
YouTubeArmando Hasudungan
76.6K viewsJul 4, 2020
Acute Inflammation Cellular Events | Rolling | Selectins | Immunology | Part 2
1:06:13
Acute Inflammation Cellular Events | Rolling | Selectins | Immunology | Part 2
YouTubeDr. Najeeb Lectures
68.6K viewsOct 13, 2024
Interleukin Therapy
Dr. Liu on Sequencing Therapy in ALK-Positive NSCLC | OncLive
Dr. Liu on Sequencing Therapy in ALK-Positive NSCLC | OncLive
onclive.com
3 weeks ago
Dr. Leleu on the Future of Later-Line Therapy in Multiple Myeloma | OncLive
Dr. Leleu on the Future of Later-Line Therapy in Multiple Myeloma | OncLive
onclive.com
3 weeks ago
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis ...
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis ...
finanznachrichten.de
3 weeks ago